Please wait

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13D/A 0001193125-18-214792 0001745437 XXXXXXXX LIVE 3 Class A Common Stock, par value $0.01 11/13/2024 false 0001723128 03168L105 Amneal Pharmaceuticals, Inc. 400 Crossing Blvd Bridgewater NJ 08807 Christine Krentz 949-409-6700 4 Gatehall Drive Parsippany NJ 07054-4513 0001745437 Patel Dipan a OO X1 23828992 0 23828992 0 23828992 N 7.7 IN The percentage of ownership of the Class A Common Stock by the Reporting Person presented in this Statement is based on 309,884,000 shares of Class A Common Stock outstanding, as disclosed in the Issuer's Quarterly Report on Form 10-Q, filed on November 11, 2024. Class A Common Stock, par value $0.01 Amneal Pharmaceuticals, Inc. 400 Crossing Blvd Bridgewater NJ 08807 The disclosure in Item 4 is hereby amended and supplemented by adding the following: Between July 15 and November 13, 2024, trusts controlled by the Reporting Person sold 3,076,081 shares of Class A Common Stock in open market transactions at prices per share between $6.75 and $9.31. The following sets forth, as of the date of this Schedule 13D, the aggregate number of shares of Class A Common Stock and percentage of Class A Common Stock beneficially owned by the Reporting Person, as well as the number of shares of Class A Common Stock as to which the Reporting Person has the sole power to vote or to direct the vote, shared power to vote or to direct the vote, sole power to dispose or to direct the disposition, or shared power to dispose or to direct the disposition of, as of the date hereof, based on 309,884,000 shares of Class A Common Stock outstanding, as disclosed in the Issuer's Quarterly Report on Form 10-Q, filed on November 11, 2024: Reporting Person - Dipan Patel Amount beneficially owned - 23,828,992 Percent of class - 7.7 Sole power to vote or to direct the vote - 23,828,992 Shared power to vote or to direct the vote - 0 Sole power to dispose or to direct the disposition - 23,828,992 Shared power to dispose or to direct the disposition - 0 The Reporting Person may be deemed to beneficially own 23,828,992 shares of Class A Common Stock held of record by trusts controlled by the Reporting Person. The information set forth in Item 4 of this Amendment No. 3 is incorporated by reference herein. None. Not applicable. Patel Dipan Dipan Patel Dipan Patel 01/23/2025